Tirelizumab Plus Surgery vs Surgery Alone for Recurrent Nasopharyngeal Carcinoma
Clinical trial NCT05092217 · UNKNOWN
Trial details
- NCT number
- NCT05092217
- Sponsor
- Eye & ENT Hospital of Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-20
- Primary completion
- 2023-10-20
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.